Clinical Trial: A Study to Evaluate Cenvacibart (REGN7508) for Secondary Stroke Prevention in Adult Participants

U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07876492) titled 'A Study to Evaluate Cenvacibart (REGN7508) for Secondary Stroke Prevention in Adult Participants' on Oct. 09.

Brief Summary: This study will test an experimental Regeneron drug called cenvacibart (REGN7508) ("study drug") compared with a placebo (a look-alike treatment with no active medicine) on top of background antiplatelet medications.

The purpose of this study is to find out if cenvacibart can safely reduce the risk of another ischemic stroke or another blood clot related events in people who have recently had an ischemic stroke or mini-stroke (TIA).

The study is looking at:

* How well cenvacibart works

* What side effects ...